Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

The impact of emotional, physical, and sexual abuse on contraceptive method selection and discontinuation.

Allsworth JE, Secura GM, Zhao Q, Madden T, Peipert JF.

Am J Public Health. 2013 Oct;103(10):1857-64. doi: 10.2105/AJPH.2013.301371. Epub 2013 Aug 15.

2.

Contraceptive continuation in Hispanic women.

Werth SR, Secura GM, Broughton HO, Jones ME, Dickey V, Peipert JF.

Am J Obstet Gynecol. 2015 Mar;212(3):312.e1-8. doi: 10.1016/j.ajog.2014.09.003. Epub 2014 Sep 9.

PMID:
25218956
3.

Continuation and satisfaction of reversible contraception.

Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D, Secura G.

Obstet Gynecol. 2011 May;117(5):1105-13. doi: 10.1097/AOG.0b013e31821188ad.

4.

Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.

Steinauer JE, Upadhyay UD, Sokoloff A, Harper CC, Diedrich JT, Drey EA.

Contraception. 2015 Dec;92(6):553-9. doi: 10.1016/j.contraception.2015.06.013. Epub 2015 Jun 17.

PMID:
26093190
5.

Perceived racial, socioeconomic and gender discrimination and its impact on contraceptive choice.

Kossler K, Kuroki LM, Allsworth JE, Secura GM, Roehl KA, Peipert JF.

Contraception. 2011 Sep;84(3):273-9. doi: 10.1016/j.contraception.2011.01.004. Epub 2011 Feb 21.

6.

Comparison of contraceptive method chosen by women with and without a recent history of induced abortion.

Madden T, Secura GM, Allsworth JE, Peipert JF.

Contraception. 2011 Dec;84(6):571-7. doi: 10.1016/j.contraception.2011.03.018. Epub 2011 May 4.

7.

An exploratory analysis of contraceptive method choice and symptoms of depression in adolescent females initiating prescription contraception.

Francis J, Presser L, Malbon K, Braun-Courville D, Linares LO.

Contraception. 2015 Apr;91(4):336-43. doi: 10.1016/j.contraception.2014.12.010. Epub 2014 Dec 30.

PMID:
25553873
8.

Hormonal and intrauterine methods for contraception for women aged 25 years and younger.

Krashin J, Tang JH, Mody S, Lopez LM.

Cochrane Database Syst Rev. 2015 Aug 17;(8):CD009805. doi: 10.1002/14651858.CD009805.pub3. Review.

PMID:
26280888
9.

Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review.

Birgisson NE, Zhao Q, Secura GM, Madden T, Peipert JF.

J Womens Health (Larchmt). 2015 May;24(5):349-53. doi: 10.1089/jwh.2015.5191. Epub 2015 Mar 31.

10.

Contraceptive provision in the VA healthcare system to women who report military sexual trauma.

Goyal V, Mattocks K, Bimla Schwarz E, Borrero S, Skanderson M, Zephyrin L, Brandt C, Haskell S.

J Womens Health (Larchmt). 2014 Sep;23(9):740-5. doi: 10.1089/jwh.2013.4466. Epub 2014 May 2.

11.

Long-acting reversible contraception.

Peck SA.

Nurs Womens Health. 2013 Oct;17(5):431-5. doi: 10.1111/1751-486X.12066.

PMID:
24138662
12.

Knowledge of contraceptive effectiveness.

Eisenberg DL, Secura GM, Madden TE, Allsworth JE, Zhao Q, Peipert JF.

Am J Obstet Gynecol. 2012 Jun;206(6):479.e1-9. doi: 10.1016/j.ajog.2012.04.012. Epub 2012 Apr 6.

13.

Effectiveness of long-acting reversible contraception.

Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, Secura GM.

N Engl J Med. 2012 May 24;366(21):1998-2007. doi: 10.1056/NEJMoa1110855.

14.

The Contraceptive CHOICE Project: recruiting women at highest risk for unintended pregnancy and sexually transmitted infection.

Spain JE, Peipert JF, Madden T, Allsworth JE, Secura GM.

J Womens Health (Larchmt). 2010 Dec;19(12):2233-8. doi: 10.1089/jwh.2010.2146. Epub 2010 Sep 11.

15.

Hormonal and intrauterine methods for contraception for women aged 25 years and younger.

Tang JH, Lopez LM, Mody S, Grimes DA.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD009805. doi: 10.1002/14651858.CD009805.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;8:CD009805.

PMID:
23152281
16.

Continuation of reversible contraception in teenagers and young women.

Rosenstock JR, Peipert JF, Madden T, Zhao Q, Secura GM.

Obstet Gynecol. 2012 Dec;120(6):1298-305. doi: http://10.1097/AOG.0b013e31827499bd.

17.

Understanding prescription adherence: pharmacy claims data from the Contraceptive CHOICE Project.

Pittman ME, Secura GM, Allsworth JE, Homco JB, Madden T, Peipert JF.

Contraception. 2011 Apr;83(4):340-5. doi: 10.1016/j.contraception.2010.08.003. Epub 2010 Sep 17.

18.

Does the expectation or perception of noncontraceptive benefits lead to higher rates of short-acting reversible contraceptive continuation for adolescents and young adult women?

Lazorwitz A, Sheeder J, Teal S, Guiahi M.

Contraception. 2015 May;91(5):380-5. doi: 10.1016/j.contraception.2015.02.003. Epub 2015 Feb 13.

PMID:
25684618
19.

Performance of a checklist to exclude pregnancy at the time of contraceptive initiation among women with a negative urine pregnancy test.

Min J, Buckel C, Secura GM, Peipert JF, Madden T.

Contraception. 2015 Jan;91(1):80-4. doi: 10.1016/j.contraception.2014.08.002. Epub 2014 Aug 8.

20.

Pharmacy claims data versus patient self-report to measure contraceptive method continuation.

Triebwasser JE, Higgins S, Secura GM, Zhao Q, Peipert JF.

Contraception. 2015 Jul;92(1):26-30. doi: 10.1016/j.contraception.2015.03.016. Epub 2015 Apr 7.

Supplemental Content

Support Center